Docoh
Loading...

51 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
companies in the United States. Mr. Yorke served as non-executive Chairman of Jed Oil and a Director/CEO at JMG Exploration. Mr. Yorke was a Fund Manager
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
States. Mr. Yorke served as non-executive Chairman of Jed Oil and a Director/CEO at JMG Exploration. Mr. Yorke was a Fund Manager and Senior Financial
D
PCSA Processa Pharmaceuticals Inc
19 Feb 21
$10.24M in equity / options, sold $10.24M, 18 investors
9:26am
Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
served as non-executive Chairman of Jed Oil and a Director/CEO at JMG Exploration. Mr. Yorke was a Fund Manager and Senior Financial Analyst, based
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
is investing in public and private companies in the United States. Mr. Yorke served as non-executive Chairman of Jed Oil and a Director/CEO at JMG
S-1/A
s6koyvbx
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
5nizo8skj9e t1i
17 Jul 20
IPO registration (amended)
5:25pm
10-K
4a48w0l
5 Mar 20
Annual report
7:00pm
S-1
nhg5i
13 Dec 19
IPO registration
5:32pm
DEF 14A
2pv9whsulb1lzhu
26 Apr 19
Definitive proxy
5:02pm
10-K/A
xan4wla gtz
5 Apr 19
Annual report (amended)
9:40pm
10-K
gpiwcz99g9pkk0f5
28 Mar 19
Annual report
5:25pm
424B3
7vh43 30mruwm1sqicu
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
d7ttnw87n95 g4gd0
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
ws6zjer41ys17j
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
jd9b3h430l cmyx25k
13 Sep 18
IPO registration (amended)
8:00pm
S-1
muz smh9kqka
29 Jul 18
IPO registration
8:00pm
D
tt7yz5anx9z2mqezh
16 May 18
$8M in equity / options, sold $2.53M, 33 investors
10:01am
10-K/A
1iluxkbs yx
16 Apr 18
Annual report (amended)
8:00pm
10-K
q2ofd gwjvkhe9hg
15 Apr 18
Annual report
8:00pm